New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 21, 2012
12:33 EDTCRM, DE, SKX, SQNM, ZLC, TLYS, STJOn The Fly: Midday Wrap
Stocks on Wall Street were higher at midday in a pre-holiday session marked by little corporate news but a fair amount of economic data. The averages opened quietly after the Labor Department reported a drop in first-time unemployment claims from the prior week, as expected. Among the other economic reports, the consumer confidence reading was slightly lower than expected and the leading economic indicators were slightly above expectations. There was little reaction to any of the reports and volume has been light, which is not surprising... ECONOMIC EVENTS: In the U.S., initial jobless claims fell to 410,000, which was in-line with forecasts. Markit's "flash" November flash PMI rose to 52.4 from 51.0 in October. The final November reading of the University of Michigan Sentiment index slipped to 82.7 from its 84.9 preliminary reading. The leading indicators edged up 0.2% in October to 96.0 from 95.8 in September. In Europe, the region's finance ministers and the IMF were unable to reach a bailout agreement for Greece and will meet again on Monday with an eye on resolving the remaining disagreements. In Asia, Japanese exports fell 6.5% in October, which was worse than expectations of a 4.9% decline... COMPANY NEWS: Salesforce.com's (CRM) Q3 results beat on the top and bottom lines and RW Baird and Wells Fargo reiterated their Outperform ratings on the stock following the report. Shares advanced 8%. Conversely, Deere (DE) shares slumped 4% after its earnings missed expectations, as did its guidance for the coming year... MAJOR MOVERS: Among the notable gainers was Sketchers (SKX), rising 12% after Susquehanna upgraded the stock to Positive from Neutral, citing valuation and product momentum. Also higher were shares of Sequenom (SQNM), up 11% after a committee of the American College of Obstetricians and Gynecologists recommended that cell-free fetal DNA testing be offered to certain at-risk patients. Among the noteworthy losers following their earnings reports were Zale (ZLC), down over 28%, and Tilly's (TLYS), down 17%. Also lower was St. Jude Medical (STJ), which fell 14% after an FDA inspection report cited serious flaws in its oversight of design changes in its Durata line of defibrillator leads... INDICES: Near 12:30 pm ET, the Dow was up 45.14, or 0.35%, to 12,833.65; the Nasdaq was up 7.07, or 0.24%, to 2,923.75; and the S&P 500 was up 2.43, or 0.18%, to 1,390.24.
News For CRM;DE;SKX;SQNM;ZLC;TLYS;STJ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 25, 2014
09:01 EDTSKXSkechers says Q3 bookings up more than 50% from last year
Skechers COO and CFO David Weinberg, as part of his rebuttal to research published yesterday by Buckingham Research Group, stated that, “With a deeper dive and channel checks conducted which is always recommended, the results would be more conclusive. As indicated by SportScan and our retail partners, we are continuing to take market share. We have seen only one material decrease in our kids business in one account in the South due to a significant planned decrease in the number of doors, though our business in the existing doors remains strong. This is already the biggest booking third quarter in the history of the Company with an over 50% increase from third quarter of last year, and the SKECHERS retail stores continue to show positive comp store increases on top of significant retail store comp increases last year. Given channel checks, SKECHERS retail performance, our incoming order rate which leads us to an increased backlog worldwide, we remain confident that our domestic and international business is strong, that our brand continues to be in demand, and that our product and marketing resonate with consumers around the world.”
08:49 EDTSKXSkechers comments on Buckingham research,says SportScan data can be skewed
Subscribe for More Information
September 24, 2014
16:22 EDTSKXOn The Fly: Closing Wrap
Stocks on Wall Street were higher after a report showed that sales of new homes rose to their highest level in over six years in August. The volume and news flow were relatively light, which may be the case again tomorrow as many market participants celebrate the Jewish holiday of Rosh Hashanah. ECONOMIC EVENTS: In the U.S., new home sales rose 18.0% in August to a 504K unit rate, which was much higher than the expected 4.4% increase. COMPANY NEWS: Bed Bath & Beyond (BBBY) advanced $4.64, or 7.4%, to $67.33 after the home goods retailer last night reported second quarter earnings and revenue that surpassed analysts' consensus estimates. The better than expected report and rise in the stock comes a day after William Blair downgraded the stock yesterday morning... Citizen Financial (CFG), the U.S. retail bank unit of Royal Bank of Scotland (RBS), became the year's second largest IPO behind Alibaba (BABA) after 140M shares began trading on the NYSE this morning. The stock ended it first day up $1.58, or 7.35%, at $23.08, which was far cry from the advance seen by another of the day's new stock debuts. CyberArk (CYBR) priced 5.36M shares at $16.00, opened for trade at $25.00 and ended the day at $29.94, making for a rise of over 87% from its IPO pricing. MAJOR MOVERS: Among the notable gainers was Acorda Therapeutics (ACOR), which advanced $8.27, or 28.18%, to $37.62 after the company agreed to acquire Civitas Therapeutics for $525M in cash. Civitas, which was private, had been scheduled to come public via an IPO that was expected to happen later this week prior to the deal announcement. Also higher was Hasbro (HAS), which rose $2.01, or 3.8%, to $54.95 after striking a deal that gives the company global rights, excluding Japan, to develop dolls based on Disney's (DIS) princess characters, as well as Frozen, beginning in 2016. Mattel (MAT), which currently holds those rights, slid 40c, or 1.25%, to $31.67 in the wake of the news. Also lower were shares of Skechers (SKX), which fell $5.69, or 9.8%, to $52.40 after research firm SportscanInfo reported that the footwear maker's sales had fallen 3% last week. However, Sterne Agee recommended buying the stock on the weakness. INDEXES: The Dow rose 154.19, or 0.9%, to 17,210.06, the Nasdaq gained 46.53, or 1.03%, to 4,555.22, and the S&P 500 added 15.53, or 0.78%, to 1,998.30.
10:44 EDTSKXSkechers falls after Sportscan says sales down 3% last week
Subscribe for More Information
10:15 EDTSKXSkechers weakness a buying opportunity, says Sterne Agee
Subscribe for More Information
10:11 EDTSKXSkechers lower after Buckingham comments on sales data
Subscribe for More Information
10:09 EDTSKXSkechers weakness a buying opportunity, says Sterne Agee
September 23, 2014
11:33 EDTDEDeere to review strategic options for crop insurance business
Deere & Company announced it will review strategic options for its crop insurance business, which underwrites policies through John Deere Insurance Company, a business unit within John Deere Financial. Deere said no formal decisions have been made and no agreements have been reached concerning the company's crop insurance operations. Citi has been retained as exclusive financial advisor to assist in the initiative. Effective risk management remains an important factor in successful farm operations, Deere noted. John Deere will continue to design, manufacture and offer technology, equipment and services in its precision agriculture offerings that enhance farming operations for customers.
09:45 EDTSTJLeerink medical devices analyst holds an analyst/industry conference call
Medical Devices Analyst Antalffy discusses the ultimate market opportunity for leadless pacers and compares Medtronic vs St. Jude Medical on an Analyst/Industry conference call to be held on September 24 at 2 pm.
08:12 EDTCRMSalesforce.com, Omnicom announce alliance
Subscribe for More Information
September 22, 2014
08:32 EDTSTJSt. Jude receives CE Mark approval of Tendril STS, IsoFlex Optim labeling
Subscribe for More Information
07:05 EDTSQNMSequenom presents new data supporting accuracy of MaterniT21 test
Sequenom announced that its wholly owned subsidiary, Sequenom Laboratories, presented patient clinical data substantiating the performance of its MaterniT21 PLUS noninvasive prenatal test in the laboratory. An ad hoc analysis of 185,000 samples from patients at high-risk for fetal chromosome aneuploidy demonstrated stable positivity rates for trisomy 21, 18 and 13, which mirror the positivity rates found in large studies on high-risk populations utilizing invasive diagnostic procedures. Additionally, Sequenom Laboratories reported performance results from clinical testing with the MaterniT21 PLUS test with Enhanced Sequencing Series. In the ad hoc analysis based on voluntary outcomes provided by clinicians, the estimated sensitivity for trisomy 21, 18 and 13 were 99.3%, 98.3% and 97.4% respectively, and the estimated specificity was >99.9% for all three trisomies. These clinical laboratory performance data are equivalent to those published in the clinical validation studies of the MaterniT21 test. Based on these performance metrics, Sequenom Laboratories estimates that the MaterniT21 PLUS test positive predictive value for trisomy 21, 18 and 13 were 99.0%, 97.6% and 92.8% respectively, and the negative predictive value was >99.9% for all three trisomies.
06:51 EDTSTJSt. Jude Medical recent weakness a buying opportunity, says Barclays
Barclays said St. Jude Medical weakness is a buying opportunity. The analyst said CardioMEMS is underappreciated by the Street and valuation compelling given sequential revenue growth. Shares are Overweight rated.
September 19, 2014
10:48 EDTCRMOracle tumbles after Q1 earnings miss estimates, Ellison steps aside as CEO
Subscribe for More Information
September 18, 2014
09:22 EDTSKXBack to school season healthy for footwear, says Sterne Agee
Subscribe for More Information
September 17, 2014
12:46 EDTSKXSkechers pullback a buying opportunity, says Wunderlich
Subscribe for More Information
12:43 EDTSKXSkechers reiterated Buy at Wunderlich
Subscribe for More Information
11:57 EDTSQNMSequenom management to meet with Maxim
Meetings to be held in New York on September 22 with a group luncheon also and in Boston on September 23 hosted by Maxim.
11:16 EDTSKXOptions with increasing implied volatility:
Options with increasing implied volatility: WB SDRL TAP AGNC IYR SKX
09:01 EDTSKXSkechers files infringement lawsuit against DB Shoe Company
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use